Loading…
Loading…
Can you elaborate on your experience with the co-pay structure in 2025? And what drove that decision to change the benefit structure in 2026?
Can you compare the relative margin profiles and different paths of margin recovery for each including which population is most addressable near term
I was hoping to get your thoughts on the risks and implications of tariffs, particularly around the impact of pharmaceutical tariffs